Friday, February 10, 2012
Just Diagnosed with Cancer? Chat with Experts

Thursday, June 04, 2009 Peace asks

Q: Arimidex 1 yr change to Tamox?

I am amost 60,double mast + radiation, ER PRO and Her +. I have been on Arimidex for almost exactly a year, have few sympthoms as being easily tired from noon on and a bit of pain on one wrist.My doctors have asked me to take tamoxifen from the very beginning ,but I opted for Arx. because of the better "recurrence" statistic acc to ATAX On my last checkup, this topic came up again and my doc still strongly suggest that I take tamoxifen . I know that tamox has been out longer and "more are known" about its effectiveness, but isn't it true that after 5 yrs of either drug, one doesn't know anyway ? since you only take tamox for 5 yrs So the recurrence and all may happen anyway after that? I hope I am making sense. So why insisting on Tamox?

Answer This
Answers (1)
6/ 4/09 11:52am

Hi - Have you asked your doctor exactly why tamoxifen is a better choice for you? All of the current data points conclusively to an aromatase inhibitor (e.g., Arimidex) showing more protection against a recurrence. Unless your doctor is super worried about osteoporosis — because that IS the downside of AIs — I can't imagine why tamoxifen is the recommendation for you.

 

Admittedly, all the data isn't in on AIs yet, as it is on tamoxifen; they're still very new, only about 10 years old, while tamoxifen has a 30+ year history. Both have their plusses and minuses as far as side effects go, but an AI will give you better protection against a recurrence - for longer than 5 years, since you generally take an AI for longer than 5 years.

 

Newest data seems to indicate that an AI for 2 years, followed by tamoxifen for 3, gives the same protection as 5 years of an AI. So you might compromise with your doctor, and suggest this regimen... Good luck - PJH

Reply
6/ 4/09 7:16pm

I so appreciate your prompt reply. I think there are so many out there who are trying to

"save themselves" considering all the options and becoming a bit "lost". I will certainly try to bring up this option with my doc about this. I have not heard about this recent indication (study), can you please point to the paper or data where 2 yrs Al and 3 yr. Tamox came from?  Is it available online? Thank you so very much !

Reply
6/ 4/09 8:03pm

You're welcome. The information as presented at the San Antonio Breast Cancer Symposium last December; it's the results of the BIG 1-98 Phase III trial. There's a good wrapup at cancerconsultants.com. Good luck with your decision- PJ

Reply
6/ 6/09 9:40pm

To update everything, I took a copy of the research results from cancerconsultations.com and discussed the options with my doc. We discussed the plus and minuses of both medications and I got what I wanted: namely, Arimidex. He said he

likes it when patients do their homework. Thank you again! I am happy with the decision. Oh, by the way,the reason all my docs recommended Tamox was, besides the long history of Tamox 30+ vs Ax 10+ and the possible side effects of the Ax and the price tag that comes with it, I had only one positive lymph node on both sides. If I had had 3 or more, it might have been a different consideration. 

 

 

 

Reply
6/ 6/09 10:27pm

Glad we could help - I hope you do well on the Arimidex, and I'm glad your doctor is interested in collaborating - that's a good thing, considering the long-term relaitonship you'll have. Good luck - PJH

Reply
Answer This

Important:
We hope you find this general health information helpful. Please note however, that this Q&A is meant to support not replace the professional medical advice you receive from your doctor. No information in the Answers above is intended to diagnose or treat any condition. The views expressed in the Answers above belong to the individuals who posted them and do not necessarily reflect the views of The HealthCentral Network. The HealthCentral Network does not review or edit content posted by our community members, but reserves the right to remove any material it deems inappropriate.